Literature DB >> 8794788

Localization of transforming growth factor-beta 1 precursor and latent TGF-beta 1 binding protein in colorectal adenomas.

J L Van Laethem1, A Resibois, M Adler, M O Peny, H Ohtani, P Robberecht.   

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine and is thought to be involved in colorectal tumorigenesis as a regulator of cell growth and differentiation. This role is mainly supported by in vitro studies while its role in vivo remains unclear. The aim of the present study was to investigate whether the TGF-beta 1 precursor (beta 1-LAP) and the latent TGF-beta 1 binding protein (LTBP) are expressed in colorectal adenomas, the presumed precursors of most of colorectal adenocarcinomas. TGF-beta 1 precursor and LTBP were examined in 35 adenomas and 10 normal colonic mucosa specimens by immunohistochemistry, using specific polyclonal antibodies. In normal colonic mucosa, beta 1-LAP was moderately expressed in epithelial crypt cells and in the stromal cells in the lamina propria. In adenomas, beta 1-LAP was localized in epithelial cells with an heterogeneous pattern and was also present in stromal cells around the adenomatous glands. LTBP was not detected in epithelial cells but was observed in stromal cells and in the extracellular matrix (ECM). beta 1-LAP expression in epithelial cells did not correlate with the grade of dysplasia, while LTBP localized in stromal cells and ECM appeared to be closely associated with areas of higher grade of dysplasia. This study is the first demonstration of both beta 1-LAP and LTBP in colorectal adenomas with different dysplasia grades. Our results suggest that TGF-beta 1 might be involved in the mechanisms controlling in vivo colorectal tumorigenesis and support a role for the stromal-associated TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794788     DOI: 10.1007/bf02088739

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences.

Authors:  T Kanzaki; A Olofsson; A Morén; C Wernstedt; U Hellman; K Miyazono; L Claesson-Welsh; C H Heldin
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  Localization of transforming growth factor-beta isotypes in lesions of the human breast.

Authors:  B K McCune; B R Mullin; K C Flanders; W J Jaffurs; L T Mullen; M B Sporn
Journal:  Hum Pathol       Date:  1992-01       Impact factor: 3.466

4.  Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes.

Authors:  A Olofsson; K Miyazono; T Kanzaki; P Colosetti; U Engström; C H Heldin
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

5.  Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.

Authors:  N M Hoosein; D E Brattain; M K McKnight; A E Levine; M G Brattain
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

6.  Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.

Authors:  R J Coffey; A S Goustin; A M Soderquist; G D Shipley; J Wolfshohl; G Carpenter; H L Moses
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

7.  Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival.

Authors:  H Friess; Y Yamanaka; M Büchler; M Ebert; H G Beger; L I Gold; M Korc
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

8.  The APC gene product in normal and tumor cells.

Authors:  K J Smith; K A Johnson; T M Bryan; D E Hill; S Markowitz; J K Willson; C Paraskeva; G M Petersen; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon.

Authors:  J A Barnard; G J Warwick; L I Gold
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

Review 10.  Transforming growth factor-beta: recent progress and new challenges.

Authors:  M B Sporn; A B Roberts
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

View more
  2 in total

1.  Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis.

Authors:  N Khalil; T V Parekh; R O'Connor; N Antman; W Kepron; T Yehaulaeshet; Y D Xu; L I Gold
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.